These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1151627)

  • 1. Quantitation of propoxyphene and its major metabolites in heroin addict plasma after large dose administration of propoxyphene napsylate.
    Nash JF; Bennett IF; Bopp RJ; Brunson MK; Sullivan HR
    J Pharm Sci; 1975 Mar; 64(3):429-33. PubMed ID: 1151627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propoxyphene and norpropoxyphene tissue concentrations in fatalities associated with propoxyphene hydrochloride and propoxyphene napsylate.
    Baselt RC; Wright JA
    Arch Toxicol; 1975 Oct; 34(2):145-52. PubMed ID: 983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum propoxyphene concentrations in a cohort of opiate addicts on long-term propoxyphene maintenance therapy. Evidence for drug tolerance in humans.
    Hartman B; Miyada DS; Pirkle H; Sedgwick P; Cravey RH; Tennant FS; Wolen RL
    J Anal Toxicol; 1988; 12(1):25-9. PubMed ID: 3352239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatographic determination of propoxyphene and norpropoxyphene in plasma.
    Cleemann M
    J Chromatogr; 1977 Feb; 132(2):287-94. PubMed ID: 833237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.
    Wolen RL; Ziege EA; Gruber CM
    Clin Pharmacol Ther; 1975 Jan; 17(1):15-20. PubMed ID: 1122667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic usefulness of propoxyphene napsylate in narcotic addiction.
    Jasinski DR; Pevnick JS; Clark SC; Griffith JD
    Arch Gen Psychiatry; 1977 Feb; 34(2):227-33. PubMed ID: 14602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantitation of meperidine, normeperidine, tramadol, propoxyphene and norpropoxyphene in human plasma using solid-phase extraction and gas chromatography/mass spectrometry: Method validation and application to cardiovascular safety of therapeutic doses.
    Fernández N; Olivera NM; Keller GA; Diez RA; Di Girolamo G; Quiroga PN
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1519-1533. PubMed ID: 28686794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLC determination of paracetamol and d-propoxyphene.
    Serfontein WJ; de Villiere LS; Villiers LS; Botha D
    S Afr J Med Sci; 1976; 41(4):297-304. PubMed ID: 1019754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of plasma levels of propoxyphene and norpropoxyphene by combined use of stable isotope labeling and selected ion monitoring.
    Sullivan HR; Emmerson JL; Marshall FK; Wood PG; McMahon RE
    Drug Metab Dispos; 1974; 2(6):526-32. PubMed ID: 4155676
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of propoxyphene napsylate in the treatment of heroin and methadone addiction.
    Inaba DS; Gay GR; Whitehead CA; Newmeyer JA; Bergin D
    West J Med; 1974 Aug; 121(2):106-11. PubMed ID: 4847425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous estimation of propoxyphene-do and propoxyphene-d2 levels by quantitative mass fragmentography. Potential utility in multidose investigations.
    Sullivan HR; Wood PG; McMahon RE
    Biomed Mass Spectrom; 1976 Oct; 3(5):212-6. PubMed ID: 974235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin.
    Nash JF; Scholz NE; Maxwell SB
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):537-45. PubMed ID: 5571353
    [No Abstract]   [Full Text] [Related]  

  • 13. Propoxyphene and norpropoxyphene quantitation in the same solid-phase extraction using Toxi-Lab Spec VC MP3 system.
    King JW; King LJ
    J Anal Toxicol; 1994; 18(4):217-9. PubMed ID: 7967543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
    Giacomini KM; Giacomini JC; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Sep; 28(3):417-24. PubMed ID: 7408401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propoxyphene napsylate (Darvon-N) treatment of heroin addicts.
    Tennant FS
    J Natl Med Assoc; 1974 Jan; 66(1):23-4, 27. PubMed ID: 4461829
    [No Abstract]   [Full Text] [Related]  

  • 16. D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
    Horsmans Y; Desager JP; Daenens C; Harvengt C; Geubel AP
    J Hepatol; 1994 Sep; 21(3):283-91. PubMed ID: 7836695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients.
    Giacomini KM; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Apr; 27(4):508-14. PubMed ID: 7357810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous self-administration of propoxyphene napsylate: case report and in-vitro studies.
    Green HM; Decker WJ
    Clin Toxicol; 1981 Sep; 18(9):1099-104. PubMed ID: 6119187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heroin detoxification. A comparison of propoxyphene and methadone.
    Tennant FS; Russell BA; Casas SK; Bleich RN
    JAMA; 1975 Jun; 232(10):1019-22. PubMed ID: 805264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.